ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.779,54
-0,58%
S&P 500
5.306,04
0,02%
US Dollar vs BRL
5,1629
0,00%
Bitcoin
68.539,85
0,37%
Brent Oil
84,135
-0,23%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRB)

  7. Cellectar Biosciences Inc (CLRB) Notícias

CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CLRB
DataHoraFonteTítuloCódigoCompanhia
24/05/202417:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CLRBCellectar Biosciences Inc
16/05/202407:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:CLRBCellectar Biosciences Inc
14/05/202407:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
14/05/202407:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
14/05/202407:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
08/05/202407:40GlobeNewswire Inc.Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals DayNASDAQ:CLRBCellectar Biosciences Inc
07/05/202407:40GlobeNewswire Inc.Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024NASDAQ:CLRBCellectar Biosciences Inc
27/03/202407:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
20/03/202407:40GlobeNewswire Inc.Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024NASDAQ:CLRBCellectar Biosciences Inc
14/03/202409:52GlobeNewswire Inc.Cellectar Biosciences to Present at the 36th Annual Roth ConferenceNASDAQ:CLRBCellectar Biosciences Inc
04/03/202408:40GlobeNewswire Inc.Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck CancerNASDAQ:CLRBCellectar Biosciences Inc
14/02/202422:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
07/02/202408:40GlobeNewswire Inc.Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CLRBCellectar Biosciences Inc
31/01/202410:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLRBCellectar Biosciences Inc
30/01/202408:40GlobeNewswire Inc.Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical StudyNASDAQ:CLRBCellectar Biosciences Inc
25/01/202408:40GlobeNewswire Inc.Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 MillionNASDAQ:CLRBCellectar Biosciences Inc
22/01/202408:40GlobeNewswire Inc.Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia PatientNASDAQ:CLRBCellectar Biosciences Inc
16/01/202408:40GlobeNewswire Inc.Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical DataNASDAQ:CLRBCellectar Biosciences Inc
12/01/202408:44GlobeNewswire Inc.Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline ResultsNASDAQ:CLRBCellectar Biosciences Inc
11/01/202408:40GlobeNewswire Inc.Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community SettingNASDAQ:CLRBCellectar Biosciences Inc
08/01/202408:30GlobeNewswire Inc.Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
03/01/202410:30GlobeNewswire Inc.Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8, 2024NASDAQ:CLRBCellectar Biosciences Inc
19/12/202310:30GlobeNewswire Inc.Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research FoundationNASDAQ:CLRBCellectar Biosciences Inc
12/12/202322:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLRBCellectar Biosciences Inc
12/12/202310:30GlobeNewswire Inc.Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC PlatformNASDAQ:CLRBCellectar Biosciences Inc
05/12/202310:30GlobeNewswire Inc.Cellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit EuropeNASDAQ:CLRBCellectar Biosciences Inc
31/10/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CLRBCellectar Biosciences Inc
25/10/202317:54Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
02/10/202317:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CLRBCellectar Biosciences Inc
22/09/202317:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CLRBCellectar Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CLRB

Seu Histórico Recente

LSE
GLIR
COIN
BIOGBP
COIN
FLNNUST
Falcon
AQSE
ISLN.GB
iShares Physical Silver ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados